Charles Schwab’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
98,177
+22,682
| +30% | +$107K | ﹤0.01% | 3163 |
|
|
2025
Q1 | $276K | Hold |
75,495
| – | – | ﹤0.01% | 3226 |
|
|
2024
Q4 | $356K | Hold |
75,495
| – | – | ﹤0.01% | 3237 |
|
|
2024
Q3 | $703K | Buy |
75,495
+7,000
| +10% | +$65.2K | ﹤0.01% | 3034 |
|
|
2024
Q2 | $394K | Buy |
68,495
+13,053
| +24% | +$75.1K | ﹤0.01% | 3288 |
|
|
2024
Q1 | $372K | Hold |
55,442
| – | – | ﹤0.01% | 3127 |
|
|
2023
Q4 | $358K | Hold |
55,442
| – | – | ﹤0.01% | 3184 |
|
|
2023
Q3 | $277K | Hold |
55,442
| – | – | ﹤0.01% | 3230 |
|
|
2023
Q2 | $390K | Buy |
55,442
+513
| +0.9% | +$3.61K | ﹤0.01% | 3160 |
|
|
2023
Q1 | $341K | Hold |
54,929
| – | – | ﹤0.01% | 3057 |
|
|
2022
Q4 | $350K | Buy |
54,929
+1,826
| +3% | +$11.7K | ﹤0.01% | 3081 |
|
|
2022
Q3 | $456K | Sell |
53,103
-24
| -0% | -$206 | ﹤0.01% | 3028 |
|
|
2022
Q2 | $723K | Buy |
53,127
+1,257
| +2% | +$17.1K | ﹤0.01% | 2917 |
|
|
2022
Q1 | $790K | Buy |
51,870
+1,059
| +2% | +$16.1K | ﹤0.01% | 2945 |
|
|
2021
Q4 | $1.16M | Buy |
50,811
+853
| +2% | +$19.5K | ﹤0.01% | 2854 |
|
|
2021
Q3 | $696K | Sell |
49,958
-21,403
| -30% | -$298K | ﹤0.01% | 3024 |
|
|
2021
Q2 | $762K | Buy |
71,361
+23,758
| +50% | +$254K | ﹤0.01% | 3022 |
|
|
2021
Q1 | $628K | Buy |
47,603
+1,647
| +4% | +$21.7K | ﹤0.01% | 3013 |
|
|
2020
Q4 | $932K | Buy |
+45,956
| New | +$932K | ﹤0.01% | 2797 |
|